VIM and intrahepatic cholangiocarcinoma: IF (Supplementary Fig. 4a–d) and ICC (Supplementary Fig. 4e, f) assays observed a decline in E-cadherin staining and an increase in vimentin staining in HT-29 and SW480 with CDX2 depletion.